CLSI POCT14
Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline
inactive
Buy Now
| Organization: | CLSI |
| Publication Date: | 1 July 2004 |
| Status: | inactive |
| Page Count: | 48 |
scope:
This document deals only with the use of POC-CT in monitoring of anticoagulant therapy with unfractionated heparin (hereafter called "heparin") and warfarin. It does not address issues related to the use of POC-CT in the evaluation of patients with suspected hemostatic disorders or use of other anticoagulants. There are many potential sites for POC-CT, such as hospitals, physicians' offices, and patients' homes. Those performing POC-CT may include healthcare professionals and patient caregivers, as well as patients.
Document History
July 1, 2020
Point-of-Care Coagulation Testing and Anticoagulation Monitoring
This guideline provides recommendations for establishing and/or assessing performance characteristics of traditional assays for coagulation assessment and anticoagulation management that are...
CLSI POCT14
July 1, 2004
Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline
This document deals only with the use of POC-CT in monitoring of anticoagulant therapy with unfractionated heparin (hereafter called "heparin") and warfarin. It does not address issues related to the...